Medicine
Spravato 28 mg/0.2 mL nasal solution
Spravato 28 mg/0.2 mL nasal solution is a prescription medicine containing Esketamine for nasal use, marketed by Janssen Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Esketamine
- Brand
- Spravato
- Strength
- 28 mg/0.2 mL
- Dosage form
- Nasal solution
- Route
- Nasal
- Packs
- 2 blister pack, 3 blister pack
- Marketing authorisation holder
- Janssen Pharmaceuticals
- Manufacturer
- Janssen Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIII
- ATC code
- N01AX14 Esketamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 March 2019
- Identifiers
- RxCUI 2119381, 2119387, 2119388 +3DailyMed set ID d81a6a79-a74a-44b7-822c-0dfa3036eaedNDC 50458-028Application NDA211243
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 kit / 1 vial, single-use in 1 blister pack / .2 mL in 1 vial, single-use | 50458-028-02 | Janssen Pharmaceuticals | 5 March 2019 |
| 3 blister pack in 1 kit / 1 vial, single-use in 1 blister pack / .2 mL in 1 vial, single-use | 50458-028-03 | Janssen Pharmaceuticals | 5 March 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Esketamine is a prescription medicine. It is available as nasal solution. MedsAcross supplies Esketamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EsketamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Spravato prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Spravato: European public assessment report (EPAR) · European Medicines Agency
Need Spravato 28 mg/0.2 mL nasal solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.